07272017Headline:

Southeast Pennsylvania, Pennsylvania

HomePennsylvaniaSoutheast Pennsylvania

    Heading
    • Mass Tort Actions Will Not Be Deterred by U.S. Supreme Court Ruling

      Mass Tort Actions Will Not Be Deterred by U.S. Supreme Court Ruling

      The U.S. Supreme Court ruled this month on a California court case concerning lawsuits against Bristol-Myers Squibb’s (BMS) Plavix blood thinner that could impact how drug and device litigation moves forward in state courts. Voting 8-1, the Justices said that […]

    • Invokana Called into Question with Latest FDA Warning

      Invokana Called into Question with Latest FDA Warning

      When Invokana was first approved by the Food and Drug Administration (FDA) in 2013, it commenced a new class of diabetes treatment. Specifically known as an SGLT2 inhibitor, canagliflozin—the trade name of Janssen Pharmaceuticals’ Invokana—was the first drug of its […]

    • When Did MoM Hip Manufacturer DePuy Know their Product Was Defective?

      When Did MoM Hip Manufacturer DePuy Know their Product Was Defective?

      Documents have recently surfaced during an investigation by The Daily Telegraph in Great Britain that show experts, both outside of and within the company, had warned DePuy of problems with their metal-on-metal hip design—going back as far as 1995. According […]

    • Hernia Mesh Cases Move Forward with MDL

      Hernia Mesh Cases Move Forward with MDL

      In December, I wrote a blog discussing the likelihood of MultiDistrict Litigation (MDL) for two manufacturers of a hernia mesh surgical device—Atrium Medical who produces C-Qur mesh and Ethicon, Inc., a subsidiary of Johnson & Johnson, who recalled their Physiomesh […]

    • Lyft: the Case Is Settled, but Not the Employment Classification

      Lyft: the Case Is Settled, but Not the Employment Classification

      A federal judge has accepted a $27 million settlement this month in a class-action lawsuit against one of the U.S.’s leading rideshare providers, Lyft. While this marks the end of a long road for drivers seeking fair compensation in the […]

    • Hyland’s Products Could Still Harm Your Baby

      Hyland’s Products Could Still Harm Your Baby

      On October 11, 2016, homeopathic medicine manufacturer Hyland’s issued a public letter to parents everywhere. Beginning with “Dear Moms and Dads…” the corporate communication went on to say that they would no longer be distributing their line of homeopathic teething […]

    • Is MiraLax Safe for Kids?

      Is MiraLax Safe for Kids?

      Even though the Mirlax label is not approved for anyone under the age of 17, pediatricians have been prescribing this constipation remedy to young children for years. Once thought gentle enough for daily use, ongoing complaints from distraught parents has […]

    • Potential Consolidation of Farxiga Cases Highlights Growing Risk

      Potential Consolidation of Farxiga Cases Highlights Growing Risk

      Earlier this month, Plaintiffs with current litigation against AstraZeneca and Bristol-Myers Squibb for injuries related to their SGLT2 diabetes drug, Farxiga, petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate their cases in the U.S. District Court of […]

    • More Trials Set for J&J’s Risperdal Despite Latest Settlement

      More Trials Set for J&J’s Risperdal Despite Latest Settlement

      Lawsuits against Johnson & Johnson (J&J) continued to increase in 2016, with new complaints filed over a mix of household items, drugs, and medical devices including Johnson’s Baby Powder, the DePuy and Pinnacle hip implants, the blood thinner Xarelto, and […]

    • Bayer Fails to Change

      Bayer Fails to Change

      On Thursday, December 29th, a petition was filed requesting that the Judicial Panel on Multidistrict Litigation (JPML) create a single docket for more than 100 lawsuits against the contraceptive device Mirena—all claiming that use of the product has resulted in […]